Pediatr. praxi. 2016;17(1):16-21 | DOI: 10.36290/ped.2016.004

ADHD in the light of contenporary psychiatry and clinical practice

doc.MUDr.Libuše Stárková, CSc.
Psychomed s. r. o. a PK FN Olomouc

Main aim of this article is to inform pediatrists about our actual view on the clinical picture, epidemiology, pathophysiology and

diagnostic procedures of ADHD and about the therapeutic approaches to this disorder. According to DSM 5, revised diagnostic and

statistical manual of mental disorders, we accept ADHD as a neurodevelopmental disorder with common onset in childhood and

lifelong duration in at least at half of the patients. ADHD can be result in various consequent problems in adult life e.g. emotional,

relational or social. Hyperactivity is often the first symptom in early childhood, severe inattention with some consequences in

academic performance is usually observed at basic school level. Comorbidity complicates diagnostic process. Proper therapy can

help to harmonize the development of personality, to build self-esteem and to improve socialization in adulthood.

Keywords: ADHD, clinical picture, pathophysiology, diagnostic process, therapy

Published: February 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stárková L. ADHD in the light of contenporary psychiatry and clinical practice. Pediatr. praxi. 2016;17(1):16-21. doi: 10.36290/ped.2016.004.
Download citation

References

  1. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition DSM 5, APA, June 2013: 947 s.
  2. Sadock BJ, Sadock VA. Kaplan and Sadock's Synopsis od Psychiatry. Behavioral Sciences/Clinical Psychiatry. Ninth edition. Philadelphia, Lippincott Williams and Wilkins 2003: 1460 p.
  3. Fiala A, Drtílková I. Perspektivní možnosti využití sTMS v léčbě ADHD. Čs. Psychiat, 2015; 111(4): 180-184.
  4. Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP, Greenstein D, et al. Attention-deficit /hyperactivity disorder is characterized by a delay in cortical maturations. Prod Natl Acad Sci USA 2007; 104(49): 19649-19654. Go to original source... Go to PubMed...
  5. Liew Z, Ritz B, et al. Attention Deficit/Hyperactivity Disorder and Childhood Autism in Association with Prenatal Exposure to Perfluoroalkyl Substances. Environ Health Perspect. 2015; 123(4): 367-373. Go to original source... Go to PubMed...
  6. Snyder MS, Rugino TA, Hornig M, Stein MA. Integration of an EEG biomarker with a clinician's ADHD evalution. Brain and Behavior, 2015; 5(4): 1-17. Go to original source... Go to PubMed...
  7. Nigg J. Attention-deficit/hyperactivity disordes and adverse health outcomes. Psychol Rev. 2013; 33(2): 215-228. Go to original source...
  8. Miodovnik A, Harstad E, Sideridis G, Huntington N. Timing of the Diagnosis od Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder. SOURCE:http://bit.ly/1QcyqYo. Pediatrics 2015. Go to original source... Go to PubMed...
  9. Cortese S, Bernardina BD, Mouren M Ch. Attention-Deficit/Hyperactivity Disordes and Binge Eating. DOI: http://dx.doi.org/10.1111/j.1753-4887.2007.tb00318.x 404-411. First published online 1 September 2007.
  10. Horrigan JP, Kohli RR. The impact of IQ on the timely diagnosis of ADHD. Poster and abstracts of the American Academy of Child and Adolescent Psychiatry 47th, Annual Meeting: October 24-29, 2000, New York, NY.
  11. Prasad S, et al. A multi-centre, randomised, open-label study of atomoxetine with standard current therapy in UK children and adolescents with ADHD. Curr Med Res Opin, 2007; 23(2): 379-394. Go to original source... Go to PubMed...
  12. Taylor JF. Jak přežít s hyperaktivitou a poruchami pozornosti. Rádce pro děti s ADHD a ADD. Praha: Portál 2012: 124 s.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.